Back to Sites

Blantyre CRS

Site Number

30301

Address

College of Medicine JHU CRS
Queen Elizabeth Central Hospital
Chipatala Avenue
Blantyre,
Malawi

IMPAACT Members at this Site

Francis Chimenya CAB Member

Evans Kachale Clinical Contact

Leslie Degnan CRS Coordinator

Dumisile Huwa CRS Coordinator

Sufia Dadabhai CRS Leader

Owen Daire CRS Staff

Jim Aizire CTU Coordinator

Jacky Jennings CTU Principal Investigator

Taha Taha CTU Principal Investigator

Dara Potter DAIDS PO

Kondwani Nkanaunena Data Manager

Macpherson Mallewa Investigator

Sharon Mambiya Investigator

Jossen Munthali Laboratory Manager/Supervisor

Dean Soko Laboratory Manager/Supervisor

Alex Siyasiya Laboratory QA/QC Coordinator

Daniel Bitton Laboratory Technician/Technologist

Mary Chadza Pharmacist

Flora Chithila Pharmacist

Liness Mwafulirwa Quality Assurance

Rachel Chamanga Study Coordinator

Rachel Chihana-Kawalazira Study Coordinator

Vitumbiko Mandiwa Study Coordinator

Amarylis Mutibura Study Coordinator

Studies at this Site

P1079: PHARMACOLOGY OF ARTEMISININ-BASED ANTIMALARIAL THERAPY

DAIDS Number

10765

Research Area

Other

Study Status

Concluded

P1084s: Maternal Infant TDF Toxicity Safety

DAIDS Number

10790

Research Area

Therapeutics

Study Status

Closed to Follow Up

P1092: Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children

DAIDS Number

11689

Research Area

Therapeutics

Study Status

Concluded

1077BF: PROMISE 1077BF

DAIDS Number

10777

Research Area

Prevention

Study Status

Participants Off Study and Primary Analysis Completed

P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study

DAIDS Number

11954

Research Area

Cure and Immunotherapy

Study Status

Enrolling

IMPAACT 2009 : Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for Primary HIV Prevention during Pregnancy and Postpartum in Adolescents and Young Women and their Infants

DAIDS Number

30020

Research Area

Therapeutics

Study Status

Closed to Follow Up

IMPAACT 2008: Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 with Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants

DAIDS Number

20735

Research Area

Cure and Immunotherapy

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2016: Evaluating a Group-Based Intervention to Improve Mental Health and ART Adherence Among Youth Living with HIV in Low Resource Settings

DAIDS Number

38506

Research Area

Brain and Mental Health

Study Status

Closed to Accrual

IMPAACT 2028: Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV

DAIDS Number

38693

Research Area

Cure and Immunotherapy

Study Status

Enrolling

IMPAACT 2039: EXCEED

DAIDS Number

38,988

Research Area

Cure and Immunotherapy

Study Status

In Development